Gut-derived Metabolite Trimethylamine Regulates Nfkb Signaling and Lipoprotein Metabolism: A Potential Therapeutic Target for Atherosclerosis

Original language	English
Article number	A121
Journal	Arteriosclerosis Thrombosis and Vascular Biology
Volume	40
Issue number	Supp 1
Publication status	Published - 30 Jun 2020

Access to Document

• https://www-ahajournals-org.queens.ezp1.qub.ac.uk/doi/abs/10.1161/atvb.40.suppl_1.121Licence: Unspecified

Student theses

• Gut bacterial metabolites in hepatic lipotoxicity and non-alcoholic fatty liver disease

  Kaluzny, S. (Author), Su, Q. (Supervisor) & Hardiman, G. (Supervisor), Jul 2023

  Student thesis: Doctoral Thesis › Doctor of Philosophy

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Kaluzny, S., & Su, Q. (2020). Gut-derived Metabolite Trimethylamine Regulates Nfkb Signaling and Lipoprotein Metabolism: A Potential Therapeutic Target for Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology, 40(Supp 1), Article A121. https://www-ahajournals-org.queens.ezp1.qub.ac.uk/doi/abs/10.1161/atvb.40.suppl_1.121

Kaluzny, Szczepan ; Su, Qiaozhu. / Gut-derived Metabolite Trimethylamine Regulates Nfkb Signaling and Lipoprotein Metabolism: A Potential Therapeutic Target for Atherosclerosis. In: Arteriosclerosis Thrombosis and Vascular Biology. 2020 ; Vol. 40, No. Supp 1.

@article{6ab9970c9df34eb09bec0daa9ba3292c,

title = "Gut-derived Metabolite Trimethylamine Regulates Nfkb Signaling and Lipoprotein Metabolism: A Potential Therapeutic Target for Atherosclerosis",

author = "Szczepan Kaluzny and Qiaozhu Su",

year = "2020",

month = jun,

day = "30",

language = "English",

volume = "40",

journal = "Arteriosclerosis Thrombosis and Vascular Biology",

issn = "1079-5642",

publisher = "Lippincott Williams and Wilkins",

number = "Supp 1",

}

Kaluzny, S & Su, Q 2020, 'Gut-derived Metabolite Trimethylamine Regulates Nfkb Signaling and Lipoprotein Metabolism: A Potential Therapeutic Target for Atherosclerosis', Arteriosclerosis Thrombosis and Vascular Biology, vol. 40, no. Supp 1, A121. <https://www-ahajournals-org.queens.ezp1.qub.ac.uk/doi/abs/10.1161/atvb.40.suppl_1.121>

Gut-derived Metabolite Trimethylamine Regulates Nfkb Signaling and Lipoprotein Metabolism: A Potential Therapeutic Target for Atherosclerosis. / Kaluzny, Szczepan; Su, Qiaozhu.
In: Arteriosclerosis Thrombosis and Vascular Biology, Vol. 40, No. Supp 1, A121, 30.06.2020.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Gut-derived Metabolite Trimethylamine Regulates Nfkb Signaling and Lipoprotein Metabolism: A Potential Therapeutic Target for Atherosclerosis

AU - Kaluzny, Szczepan

AU - Su, Qiaozhu

PY - 2020/6/30

Y1 - 2020/6/30

M3 - Meeting abstract

SN - 1079-5642

VL - 40

JO - Arteriosclerosis Thrombosis and Vascular Biology

JF - Arteriosclerosis Thrombosis and Vascular Biology

IS - Supp 1

M1 - A121

ER -

Kaluzny S, Su Q. Gut-derived Metabolite Trimethylamine Regulates Nfkb Signaling and Lipoprotein Metabolism: A Potential Therapeutic Target for Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 2020 Jun 30;40(Supp 1):A121.